LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.

    Burster, Timo / Macmillan, Henriette / Hou, Tieying / Schilling, James / Truong, Phi / Boehm, Bernhard O / Zou, Fang / Lau, Kenneth / Strohman, Michael / Schaffert, Steven / Busch, Robert / Mellins, Elizabeth D

    Immunology

    2010  Volume 130, Issue 3, Page(s) 436–446

    Abstract: Summary: The expression of major histocompatibility complex class II (MHC II) molecules is post ... Thus, in vivo, the CatG cleavage site is sterically inaccessible or masked by associated molecules ... A combination of intrinsic and context-dependent proteolytic resistance may allow peptide capture by MHC II ...

    Abstract Summary: The expression of major histocompatibility complex class II (MHC II) molecules is post-translationally regulated by endocytic protein turnover. Here, we identified the serine protease cathepsin G (CatG) as an MHC II-degrading protease by in vitro screening and examined its role in MHC II turnover in vivo. CatG, uniquely among endocytic proteases tested, initiated cleavage of detergent-solubilized native and recombinant soluble MHC II molecules. CatG cleaved human leukocyte antigen (HLA)-DR isolated from both HLA-DM-expressing and DM-null cells. Even following CatG cleavage, peptide binding was retained by pre-loaded, soluble recombinant HLA-DR. MHC II cleavage occurred on the loop between fx1 and fx2 of the membrane-proximal beta2 domain. All allelic variants of HLA-DR tested and murine I-A(g7) class II molecules were susceptible, whereas murine I-E(k) and HLA-DM were not, consistent with their altered sequence at the P1' position of the CatG cleavage site. CatG effects were reduced on HLA-DR molecules with DRB mutations in the region implicated in interaction with HLA-DM. In contrast, addition of CatG to intact B-lymphoblastoid cell lines (B-LCLs) did not cause degradation of membrane-bound MHC II. Moreover, inhibition or genetic ablation of CatG in primary antigen-presenting cells did not cause accumulation of MHC II molecules. Thus, in vivo, the CatG cleavage site is sterically inaccessible or masked by associated molecules. A combination of intrinsic and context-dependent proteolytic resistance may allow peptide capture by MHC II molecules in harshly proteolytic endocytic compartments, as well as persistent antigen presentation in acute inflammatory settings with extracellular proteolysis.
    MeSH term(s) Amino Acid Sequence ; Amino Acid Substitution ; Animals ; B-Lymphocytes/metabolism ; Cathepsin G/antagonists & inhibitors ; Cathepsin G/chemistry ; Cathepsin G/genetics ; Cathepsin G/metabolism ; Cathepsins/metabolism ; Cell Line ; Dendritic Cells/metabolism ; HLA-D Antigens/genetics ; HLA-D Antigens/metabolism ; HLA-DR Antigens/genetics ; HLA-DR Antigens/metabolism ; HLA-DR1 Antigen/genetics ; HLA-DR1 Antigen/metabolism ; HLA-DR3 Antigen/genetics ; HLA-DR3 Antigen/metabolism ; Hemagglutinin Glycoproteins, Influenza Virus/metabolism ; Histocompatibility Antigens Class II/genetics ; Histocompatibility Antigens Class II/metabolism ; Histocompatibility Antigens Class II/pharmacology ; Humans ; Macrophages/metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Models, Molecular ; Molecular Sequence Data ; Peptide Fragments/analysis ; Peptide Fragments/metabolism ; Peptides/metabolism ; Polymorphism, Genetic/genetics ; Protein Binding/physiology ; Protein Processing, Post-Translational ; Recombinant Proteins/metabolism ; Sequence Alignment
    Chemical Substances HLA-D Antigens ; HLA-DM antigens ; HLA-DR Antigens ; HLA-DR1 Antigen ; HLA-DR3 Antigen ; Hemagglutinin Glycoproteins, Influenza Virus ; Histocompatibility Antigens Class II ; I-E-antigen ; Peptide Fragments ; Peptides ; Recombinant Proteins ; influenza hemagglutinin (306-318) ; Cathepsins (EC 3.4.-) ; Cathepsin G (EC 3.4.21.20)
    Language English
    Publishing date 2010-03-17
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 80124-0
    ISSN 1365-2567 ; 0019-2805 ; 0953-4954
    ISSN (online) 1365-2567
    ISSN 0019-2805 ; 0953-4954
    DOI 10.1111/j.1365-2567.2010.03247.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules

    Burster, Timo / Macmillan, Henriette / Hou, Tieying / Schilling, James / Truong, Phi / Boehm, Bernhard O / Zou, Fang / Lau, Kenneth / Strohman, Michael / Schaffert, Steven / Busch, Robert / Mellins, Elizabeth D

    Immunology. 2010 July, v. 130, no. 3

    2010  

    Abstract: The expression of major histocompatibility complex class II (MHC II) molecules is post ... Thus, in vivo, the CatG cleavage site is sterically inaccessible or masked by associated molecules ... A combination of intrinsic and context-dependent proteolytic resistance may allow peptide capture by MHC II ...

    Abstract The expression of major histocompatibility complex class II (MHC II) molecules is post-translationally regulated by endocytic protein turnover. Here, we identified the serine protease cathepsin G (CatG) as an MHC II-degrading protease by in vitro screening and examined its role in MHC II turnover in vivo. CatG, uniquely among endocytic proteases tested, initiated cleavage of detergent-solubilized native and recombinant soluble MHC II molecules. CatG cleaved human leukocyte antigen (HLA)-DR isolated from both HLA-DM-expressing and DM-null cells. Even following CatG cleavage, peptide binding was retained by pre-loaded, soluble recombinant HLA-DR. MHC II cleavage occurred on the loop between fx1 and fx2 of the membrane-proximal β2 domain. All allelic variants of HLA-DR tested and murine I-Ag⁷ class II molecules were susceptible, whereas murine I-Ek and HLA-DM were not, consistent with their altered sequence at the P1' position of the CatG cleavage site. CatG effects were reduced on HLA-DR molecules with DRB mutations in the region implicated in interaction with HLA-DM. In contrast, addition of CatG to intact B-lymphoblastoid cell lines (B-LCLs) did not cause degradation of membrane-bound MHC II. Moreover, inhibition or genetic ablation of CatG in primary antigen-presenting cells did not cause accumulation of MHC II molecules. Thus, in vivo, the CatG cleavage site is sterically inaccessible or masked by associated molecules. A combination of intrinsic and context-dependent proteolytic resistance may allow peptide capture by MHC II molecules in harshly proteolytic endocytic compartments, as well as persistent antigen presentation in acute inflammatory settings with extracellular proteolysis.
    Keywords antigen presentation ; proteolysis ; cathepsin G
    Language English
    Dates of publication 2010-07
    Size p. 436-446.
    Publisher Blackwell Publishing Ltd
    Publishing place Oxford, UK
    Document type Article
    ZDB-ID 80124-0
    ISSN 1365-2567 ; 0019-2805 ; 0953-4954
    ISSN (online) 1365-2567
    ISSN 0019-2805 ; 0953-4954
    DOI 10.1111/j.1365-2567.2010.03247.x
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top